Aurinia Pharmaceuticals (AUPH) Plans Single Voclosporin Phase 3 as LN Treatment
Go back to Aurinia Pharmaceuticals (AUPH) Plans Single Voclosporin Phase 3 as LN Treatment| Hauppauge Digital, Inc. (NASDAQ: AUP) | Delayed: 0.47 +0.23 (95.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.24 | 52 Week High | $0.67 | |||
| Open | $0.25 | 52 Week Low | $0.25 | |||
| Day High | $0.67 | P/E | 0.87 | |||
| Day Low | $0.25 | EPS | $0.54 | |||
| Volume | 9,138 | |||||
| (NASDAQ: AUPH) | Delayed: 4.87 -0.16 (3.18%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.03 | 52 Week High | $5.69 | |||
| Open | $4.96 | 52 Week Low | $1.42 | |||
| Day High | $5.01 | P/E | N/A | |||
| Day Low | $4.77 | EPS | $0.00 | |||
| Volume | 1,540,488 | |||||
